Skip to main content
Published locations for Daratumumab shows limited benefit in transfusion-dependent patients with low- to intermediate-risk MDS
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Daratumumab shows limited benefit in transfusion-dependent patients with low- to intermediate-risk MDS
User login
Username
Password
Reset your password
/content/daratumumab-shows-limited-benefit-transfusion-dependent-patients-low-intermediate-risk-mds
/hematology-oncology/article/236822/myelodysplastic-syndrome/daratumumab-shows-limited-benefit